Dettmer Matthew, Holthaus Christopher V, Fuller Brian M
*Cooper Medical School of Rowan University, Cooper University Hospital, Camden, New Jersey; and †Division of Emergency Medicine, and ‡Department of Anesthesiology, Division of Critical Care, Division of Emergency Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri.
Shock. 2015 Jan;43(1):55-61. doi: 10.1097/SHK.0000000000000260.
Monitoring in the setting of critical illness must be linked to beneficial therapy to affect clinical outcome. Elevated serum lactate is associated with an increase in mortality in emergency department (ED) patients with severe sepsis and septic shock. The reduction of lactate levels toward normal during acute resuscitation is associated with improved clinical outcomes. The majority of data demonstrating the interventions used to achieve a reduction in lactate levels and the associated clinical outcomes have been obtained during protocolized randomized trials. We therefore conducted a retrospective observational cohort study of 243 adult patients with severe sepsis and septic shock to assess the interventions associated with nonprotocolized serial lactate monitoring and to assess clinical outcomes. A multivariable model was used to assess outcome differences between the serial lactate (SL) and no serial lactate (NL) cohorts. The SL group received more crystalloid resuscitation (3.6 L vs. 2.5 L; P < 0.01), central venous oxygen saturation monitoring (30% vs. 12%; P < 0.01), and central venous pressure monitoring (23.5% vs. 11.8%; P = 0.02). By day 28, a total of 31 patients in the SL group (23.5%) and 44 in the NL group (39.6%) had died. Multivariable logistic regression analysis demonstrated that the lack of serial lactate monitoring was independently associated with mortality (adjusted odds ratio, 2.09; 95% confidence interval [CI], 1.12 - 3.89; P = 0.02). The SL group also showed greater improvement in 24-h Sequential Organ Failure Assessment scores (1.16 vs. 0.19; P = 0.03), decreased intensive care unit length of stay in days (4.6 vs. 6.0; P = 0.04), and more ventilator-free (19.9 vs. 16; P = 0.05) and vasopressor-free (21.6 vs. 17.9; P = 0.02) days. In the setting of routine clinical care, serial lactate monitoring is associated with an increase in crystalloid administration, resuscitation interventions, and improved clinical outcomes in ED patients with severe sepsis and septic shock. This suggests that serial lactate monitoring, targeting a reduction in lactate levels to normal, is a generalizable resuscitation target in the ED.
危重症情况下的监测必须与有益的治疗措施相关联,才能影响临床结局。血清乳酸水平升高与急诊科(ED)严重脓毒症和脓毒性休克患者的死亡率增加相关。急性复苏期间将乳酸水平降至正常与改善临床结局相关。大多数表明用于降低乳酸水平的干预措施及其相关临床结局的数据是在标准化随机试验中获得的。因此,我们对243例严重脓毒症和脓毒性休克成年患者进行了一项回顾性观察队列研究,以评估与非标准化连续乳酸监测相关的干预措施,并评估临床结局。使用多变量模型评估连续乳酸(SL)组和非连续乳酸(NL)组之间的结局差异。SL组接受了更多的晶体液复苏(3.6 L对2.5 L;P<0.01)、中心静脉血氧饱和度监测(30%对12%;P<0.01)和中心静脉压监测(23.5%对11.8%;P = 0.02)。到第28天,SL组共有31例患者(23.5%)死亡,NL组有44例患者(39.6%)死亡。多变量逻辑回归分析表明,缺乏连续乳酸监测与死亡率独立相关(调整后的优势比为2.09;95%置信区间[CI]为1.12 - 3.89;P = 0.02)。SL组在24小时序贯器官衰竭评估评分方面也有更大改善(1.16对0.19;P = 0.03),重症监护病房住院天数减少(4.6天对6.0天;P = 0.04),无呼吸机天数(19.9天对16天;P = 0.05)和无血管活性药物天数(21.6天对17.9天;P = 0.02)更多。在常规临床护理环境中,连续乳酸监测与严重脓毒症和脓毒性休克ED患者晶体液输注量增加、复苏干预措施增加以及临床结局改善相关。这表明以将乳酸水平降至正常为目标的连续乳酸监测是ED中一种可推广的复苏目标。